U.S. appellate judges seem divided on gene editing patents decision
(Reuters) - U.S. appeals court judges appear divided over whether to allow a research center affiliated with MIT and Harvard to keep patents potentially worth billions of dollars on a groundbreaking gene editing technology known as CRISPR.
from Reuters: Health News https://reut.rs/2HEKR64
http://bit.ly/2zwRqiM